Angiology最新文献_第10页

Trends, Characteristics and Outcomes in Breast Cancer Survivors With STEMI. STEMI乳腺癌幸存者的趋势、特征和结局。

IF 2.2 3区医学

Angiology Pub Date : 2026-03-01 Epub Date: 2025-01-22 DOI: 10.1177/00033197241308045

Jia Ee Chia, Song Peng Ang, Muhammed Haris Usman, Chayakrit Krittanawong, Debabrata Mukherjee

{"title":"Trends, Characteristics and Outcomes in Breast Cancer Survivors With STEMI.","authors":"Jia Ee Chia, Song Peng Ang, Muhammed Haris Usman, Chayakrit Krittanawong, Debabrata Mukherjee","doi":"10.1177/00033197241308045","DOIUrl":"10.1177/00033197241308045","url":null,"abstract":"Breast cancer is the most common malignancy among women. While advances in detection and treatment have improved survival, breast cancer survivors face an increased risk of cardiovascular disease. However, limited data exist on cardiac outcomes after ST-elevation myocardial infarction (STEMI) in this population. This retrospective cohort study analyzed the National Inpatient Sample (NIS) database (2016-2021). Adult women hospitalized with STEMI were categorized as breast cancer survivors or without a history of breast cancer. The primary outcome was in-hospital mortality, with multivariable logistic regression used to adjust for confounders. A total of 369,070 adult females were included (breast cancer survivors, n = 13,890; without breast cancer, n = 355,180). Breast cancer survivors were older with more cardiovascular comorbidities. After adjustment, breast cancer survivors had lower odds of in-hospital mortality (adjusted odds ratio [aOR] 0.82, 95% CI 0.72-0.93), cardiogenic shock (aOR 0.88, 95% CI 0.77-0.99), and acute kidney injury (aOR 0.85, 95% CI 0.76-0.95). Breast cancer survivors hospitalized for STEMI had lower in-hospital mortality and complications, compared with those without breast cancer. These hypothesis-generating findings suggest that advances in oncology and cardiovascular care may contribute to improved outcomes.","PeriodicalId":8264,"journal":{"name":"Angiology","volume":" ","pages":"375-384"},"PeriodicalIF":2.2,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142998956","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Single Versus Double Perclose Vascular Closure Device in Transfemoral Transcatheter Aortic Valve Implantation: A Systematic Review and Meta-Analysis. 经股动脉主动脉瓣置入术中单瓣与双瓣血管闭合装置：系统回顾和荟萃分析。

IF 2.2 3区医学

Angiology Pub Date : 2026-02-25 DOI: 10.1177/00033197261422791

Nikolaos Vythoulkas-Biotis, Theoni Theodoropoulou, Ioannis Gialamas, Antonios Lysandrou, Panteleimon Pantelidis, Georgios E Zakynthinos, Evangelos Oikonomou, Efstratios Katsianos, Manolis Vavuranakis, Gerasimos Siasos, Konstantinos Kalogeras

{"title":"Single Versus Double Perclose Vascular Closure Device in Transfemoral Transcatheter Aortic Valve Implantation: A Systematic Review and Meta-Analysis.","authors":"Nikolaos Vythoulkas-Biotis, Theoni Theodoropoulou, Ioannis Gialamas, Antonios Lysandrou, Panteleimon Pantelidis, Georgios E Zakynthinos, Evangelos Oikonomou, Efstratios Katsianos, Manolis Vavuranakis, Gerasimos Siasos, Konstantinos Kalogeras","doi":"10.1177/00033197261422791","DOIUrl":"https://doi.org/10.1177/00033197261422791","url":null,"abstract":"Complications related to vascular closure devices (VCDs) remain relatively common after transcatheter aortic valve implantation (TAVI), while the optimal suture-based strategy remains a subject of debate. This systematic review and meta-analysis aim to evaluate the efficacy and safety of single versus double Perclose VCD in patients undergoing transfemoral TAVI. A literature search was conducted across PubMed, Scopus, and Cochrane databases to identify appropriate studies. The primary outcome was technical success; secondary outcomes included vascular and bleeding complications, bailout interventions, and all-cause mortality. Seven studies (3940 patients) fulfilled the inclusion criteria. Technical success was comparable between the two strategies (relative risk [RR]: .89; 95% confidence interval [CI]: .64-1.22), while the single Perclose strategy was associated with a lower risk of major vascular complications (RR: .61; 95% CI: .40-.92), major bleeding (RR: .28; 95% CI: .11-.73) and bailout surgical interventions (RR: .45; 95% CI: .24-.84). There were no differences in minor vascular complications and all-cause mortality. Stepwise closure with the upfront single Perclose strategy demonstrated comparable technical success and a more favorable safety profile regarding major vascular complications and bleeding compared with the double Perclose strategy. Additional randomized controlled trials are essential to validate these findings.","PeriodicalId":8264,"journal":{"name":"Angiology","volume":" ","pages":"33197261422791"},"PeriodicalIF":2.2,"publicationDate":"2026-02-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147282195","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Letter: New Mechanisms of the Postprandial Atherogenic Index in Predicting Contrast-Induced Nephropathy: Hemodynamic Alterations, Lipid Nephrotoxicity, and Neurohormonal Activation. 信：餐后动脉粥样硬化指数预测造影剂肾病的新机制：血流动力学改变、脂质肾毒性和神经激素激活。

IF 2.2 3区医学

Angiology Pub Date : 2026-02-24 DOI: 10.1177/00033197261427078

Zeping Zhang, Yuqing Sun, Man Li

引用次数: 0

Contemporary Trends, In-Hospital Outcomes, and Adverse Prognosticators of Sickle Cell Patients with Cardiovascular and Thromboembolic Complications: A National Database Analysis. 镰状细胞患者心血管和血栓栓塞并发症的当代趋势、住院结果和不良预后：一个国家数据库分析

IF 2.2 3区医学

Angiology Pub Date : 2026-02-24 DOI: 10.1177/00033197261418309

Harsha Sanaka, Chin-I Cheng, Elio Haroun, Ankit Agrawal, Aro Daniela Arockiam, Tom Kai Ming Wang

{"title":"Contemporary Trends, In-Hospital Outcomes, and Adverse Prognosticators of Sickle Cell Patients with Cardiovascular and Thromboembolic Complications: A National Database Analysis.","authors":"Harsha Sanaka, Chin-I Cheng, Elio Haroun, Ankit Agrawal, Aro Daniela Arockiam, Tom Kai Ming Wang","doi":"10.1177/00033197261418309","DOIUrl":"https://doi.org/10.1177/00033197261418309","url":null,"abstract":"Sickle cell disease (SCD) leads to red blood cell deformities resulting in vaso-occlusion and multiorgan damage. Outcomes and adverse prognosticators among SCD patients with cardiovascular and thromboembolic (CVTE) complications are not well established. Therefore, we aimed to assess characteristics, outcomes, and mortality predictors for hospitalized SCD patients with CVTE complications. The National Inpatient Sample (2012-2021) was queried using ICD-9 and -10 codes for CVTE complications and relevant data in SCD patients. Mortality trends were examined with the Cochran-Armitage test, and factors associated with mortality were identified with multivariable logistic regression accounting for the weighted survey design. There were 1 388 310 SCD-related hospitalizations (mean age 31.3 ± 0.1 years; 56.4% female), of which 441 820 (31.8%) involved CVTE complications, including deep vein thrombosis (33.6%), pulmonary embolism (27%), acute chest syndrome (26%), congestive heart failure (21.3%), and pulmonary hypertension (18.2%). In-hospital mortality was higher in patients with CVTE complications (1.5% vs 0.3%, P < .0001). Charlson comorbidity index, myocardial infarction, arrhythmias, stroke, pulmonary embolism, and COVID-19 infection were identified as predictors of inpatient mortality. In conclusion, CVTE complications are associated with increased inpatient mortality. Early recognition of mortality predictors may support more effective risk stratification and timely interventions.","PeriodicalId":8264,"journal":{"name":"Angiology","volume":" ","pages":"33197261418309"},"PeriodicalIF":2.2,"publicationDate":"2026-02-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147282073","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Letter: Hs-CRP/ALB Levels as a Novel Biomarker of Prognosis in Patients With Coronary Heart Disease. Hs-CRP/ALB水平作为冠心病患者预后的新生物标志物

IF 2.2 3区医学

Angiology Pub Date : 2026-02-23 DOI: 10.1177/00033197261428507

Fei Li

引用次数: 0

The Letter to Editor Regarding "Assessing Disparities in Long-Term Outcomes in Non-ST Elevation Myocardial Infarction According to Presence of Obstructive Airways Disease". 致编辑的关于“根据阻塞性气道疾病的存在评估非st段抬高型心肌梗死的长期结局差异”的信。

IF 2.2 3区医学

Angiology Pub Date : 2026-02-23 DOI: 10.1177/00033197261427852

Jiayi Chen

引用次数: 0

Letter: Prognostic Value of the Systemic Immune-Inflammation Index in Patients With Acute Myocardial Infarction: A Systematic Review and Meta-Analysis. 全身性免疫炎症指数在急性心肌梗死患者中的预后价值：一项系统综述和荟萃分析。